Literature DB >> 9342444

Computer simulation of a breast cancer metastasis model.

M W Retsky1, R Demicheli, D E Swartzendruber, P D Bame, R H Wardwell, G Bonadonna, J F Speer, P Valagussa.   

Abstract

Recent analysis of relapse data from 1173 untreated early stage breast cancer patients with 16-20 year follow-up shows that frequency of relapse has a double peaked distribution. There is a sharp peak at 18 months, a nadir at 50 months and a broad peak at 60 months. Patients with larger tumors more frequently relapse in the first peak while those with smaller tumors relapse equally in both peaks. No existing theory of tumor growth predicts this effect. To help understand this phenomenon, a model of metastatic growth has been proposed consisting of three distinct phases: a single cell, an avascular growth, and a vascularized lesion. Computer simulation of this model shows that the second relapse peak can be explained by a steady stochastic progression from one phase to the next phase. However, to account for the first relapse peak, a sudden perturbation of the development at the time of surgery is necessary. Model simulations predict that patients who relapse in the second peak would have micrometastases in states of relatively low chemosensitivity when adjuvant therapy is normally administered. The simulation predicts that 15% of T1, 39% of T2, and 51% of T3 staged patients benefit from adjuvant chemotherapy, partially offsetting the advantage of early detection. This suggests that early detection and adjuvant chemotherapy may not be symbiotic strategies. New therapies are needed to benefit patients who would relapse in the second peak.

Entities:  

Mesh:

Year:  1997        PMID: 9342444     DOI: 10.1023/a:1005849301420

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  28 in total

1.  Modeling Spontaneous Metastasis following Surgery: An In Vivo-In Silico Approach.

Authors:  Sebastien Benzekry; Amanda Tracz; Michalis Mastri; Ryan Corbelli; Dominique Barbolosi; John M L Ebos
Journal:  Cancer Res       Date:  2015-10-28       Impact factor: 12.701

Review 2.  The dynamics of drug resistance: a mathematical perspective.

Authors:  Orit Lavi; Michael M Gottesman; Doron Levy
Journal:  Drug Resist Updat       Date:  2012-03-03       Impact factor: 18.500

3.  Sample size re-estimation in a breast cancer trial.

Authors:  Erinn M Hade; David Jarjoura
Journal:  Clin Trials       Date:  2010-04-14       Impact factor: 2.486

4.  Modeling the connection between primary and metastatic tumors.

Authors:  David Diego; Gabriel F Calvo; Víctor M Pérez-García
Journal:  J Math Biol       Date:  2012-07-25       Impact factor: 2.259

Review 5.  Molecular biology of breast cancer metastasis. The use of mathematical models to determine relapse and to predict response to chemotherapy in breast cancer.

Authors:  S E Clare; F Nakhlis; J C Panetta
Journal:  Breast Cancer Res       Date:  2000-07-21       Impact factor: 6.466

Review 6.  Adjuvant hormonal therapy in premenopausal women with operable breast cancer: not-so-peripheral perspectives.

Authors:  Richard R Love
Journal:  Oncology (Williston Park)       Date:  2010-04-15       Impact factor: 2.990

7.  Early postoperative paclitaxel followed by concurrent paclitaxel and cisplatin with radiation therapy for patients with resected high-risk head and neck squamous cell carcinoma: report of the phase II trial RTOG 0024.

Authors:  David I Rosenthal; Jonathan Harris; Arlene A Forastiere; Randal S Weber; John A Ridge; Jeffrey N Myers; Adam S Garden; Michael R Kuettel; Kulbir Sidhu; Christopher J Schultz; Andy Trotti; K Kian Ang
Journal:  J Clin Oncol       Date:  2009-08-31       Impact factor: 44.544

8.  New concepts in breast cancer emerge from analyzing clinical data using numerical algorithms.

Authors:  Michael Retsky
Journal:  Int J Environ Res Public Health       Date:  2009-01-20       Impact factor: 3.390

9.  What can be learnt about disease progression in breast cancer dormancy from relapse data?

Authors:  Lisa Willis; Trevor A Graham; Tomás Alarcón; Malcolm R Alison; Ian P M Tomlinson; Karen M Page
Journal:  PLoS One       Date:  2013-05-06       Impact factor: 3.240

10.  Effects of Surgery and Chemotherapy on Metastatic Progression of Prostate Cancer: Evidence from the Natural History of the Disease Reconstructed through Mathematical Modeling.

Authors:  Leonid Hanin; Marco Zaider
Journal:  Cancers (Basel)       Date:  2011-09-20       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.